MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)

Manufacturer: MPM Medical LLC
Effective date: 2026-03-30
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 01:52:08

Label at a glance#

ProductREGENECARE HA

Active ingredientLIDOCAINE HYDROCHLORIDE

Label structure8 sections

Indications and uses

For the temporary relief of pain and itching associated with minor burns sunburn minor cuts scrapes insect bites minor skin irritations

Dosage and administration

Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: Consult a physician prior to use.

Storage and handling

Store at room temperature Avoid freezing and excessive heat

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine HCl 2%

Purpose

OTC - PURPOSE SECTION

Topical Analgesic

Uses

INDICATIONS & USAGE SECTION

For the temporary relief of pain and itching associated with

minor burns
sunburn
minor cuts
scrapes
insect bites
minor skin irritations

Warnings

WARNINGS SECTION

For external use only

If swallowed, get medical help or contatct a Poison Control Center right away

Avoid contact with the eyes

If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult with a doctor

Do not use in large quantities, particularly over raw surfaces or blistered areas

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.

Children under 2 years of age: Consult a physician prior to use.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature

Avoid freezing and excessive heat

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aloe vera varvadensis leaf extract, Benzethonium chloride, Carbomer, Glycerin, Procollagen, Sodium hyaluronate, Triethanolamine, Water

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal DisplayRegeneCare HA Gel

MP00108 4mL Label

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1011852	Lidocaine (Topical)	lidocaine hydrochloride 0.02 MG/MG Topical Gel	SCD Active
1012594	REGENECARE (Topical)	lidocaine hydrochloride 20 MG/ML Topical Spray [Regenecare]	SBD Active

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1011852	lidocaine HCl 2 % Topical Gel	PSN	8
2604879	REGENECARE HA 2 % Topical Gel	PSN	8
2604879	lidocaine hydrochloride 0.02 MG/MG Topical Gel [Regenecare]	SBD	8
1011852	lidocaine hydrochloride 0.02 MG/MG Topical Gel	SCD	8
1011852	lidocaine hydrochloride 2 % Topical Jelly	SY	8
2604879	Regenecare 2 % Topical Gel	SY	8

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
LIDOCAINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Barcode	EAN-13	0366977112055	GTIN-13: 0366977112055 EAN-13: 0366977112055 GTIN-12: 366977112055 UPC-A: 366977112055 GTIN storage (14 digits): 00366977112055	MP00112 Regenecare HA Gel 0.5oz.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
66977-107-03	2024-07-16	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)
66977-107-03	2024-07-16	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)
66977-107-03	2024-01-30	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)
66977-107-03	2024-01-30	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)
66977-107-03	2022-03-08	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)
66977-107-03	2022-03-08	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)
66977-107-25	2022-03-08	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)
66977-107-25	2022-03-08	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)
66977-107-03	2019-11-27	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)
66977-107-03	2019-11-27	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)
66977-107-25	2019-11-27	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MPoo108 - 4mL)
66977-107-25	2019-11-27	C162847	48780-1	9855d018-d90a-cd31-e053-dbdaa90ab51a	MPM Regenecare HA Gel (MP00107 - 3oz., MP00108 - 4mL, MP00112 - 0.5oz)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
66977-107-03	REGENECARE HA	85 g in 1 TUBE	GEL	85	8
66977-107-04	REGENECARE HA	4 g in 1 TUBE	GEL	4	8
66977-107-05	REGENECARE HA	14.17 g in 1 TUBE	GEL	14.17	8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
66977-107-03	GM - Gram	66977-107	0f6fe96d-9a40-449e-b50a-c86e20b35336	1	2013-07-02
66977-107-25	ML - Milliliter	66977-107	eae63e2a-b3b6-4bd0-a32d-dc55d058f221	1	2013-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
LIDOCAINE HYDROCHLORIDE	ACTIVE INGREDIENT	V13007Z41A	1
LIDOCAINE	ACTIVE MOIETY	98PI200987	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	1
BENZETHONIUM CHLORIDE	INACTIVE INGREDIENT	PH41D05744	1
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	4Q93RCW27E	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	1
HYALURONATE SODIUM	INACTIVE INGREDIENT	YSE9PPT4TH	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

REGENECARE HA
lidocaine HCl
MARINE COLLAGEN, SOLUBLE
ALOE VERA LEAF
BENZETHONIUM CHLORIDE
CARBOMER 940
GLYCERIN
HYALURONATE SODIUM
TROLAMINE
WATER
LIDOCAINE HYDROCHLORIDE
LIDOCAINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
66977-107	66977-107-03, 66977-107-04, 66977-107-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
MARINE COLLAGEN, SOLUBLE	8JC99XGU4W	IACT
ALOE VERA LEAF	ZY81Z83H0X	IACT
BENZETHONIUM CHLORIDE	PH41D05744	IACT
CARBOMER 940	4Q93RCW27E	IACT
GLYCERIN	PDC6A3C0OX	IACT
HYALURONATE SODIUM	YSE9PPT4TH	IACT
TROLAMINE	9O3K93S3TK	IACT
WATER	059QF0KO0R	IACT
LIDOCAINE HYDROCHLORIDE	V13007Z41A	ACTIR

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
Version	Effective date	Source	Hydrated
7	2025-12-11	monthly-update	2026-06-03 17:45:47

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 20 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
HYALURONATE SODIUM	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	GEL / TOPICAL		85 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
HYALURONATE SODIUM	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
BENZETHONIUM CHLORIDE	BENZETHONIUM CHLORIDE	PH41D05744	CREAM / TOPICAL	NA		Exact identifier — unii+route 4 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
BENZETHONIUM CHLORIDE	BENZETHONIUM CHLORIDE	PH41D05744	CREAM / TOPICAL	NA		Exact identifier — unii+route 4 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	GEL / TOPICAL		85 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
HYALURONATE SODIUM	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	GEL / TOPICAL		85 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	4Q93RCW27E	GEL / TOPICAL		85 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
HYALURONATE SODIUM	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates
BENZETHONIUM CHLORIDE	BENZETHONIUM CHLORIDE	PH41D05744	CREAM / TOPICAL	NA		Exact identifier — unii+route 4 equally ranked IID candidates
BENZETHONIUM CHLORIDE	BENZETHONIUM CHLORIDE	PH41D05744	CREAM / TOPICAL	NA		Exact identifier — unii+route 4 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
REGENECARE HA	LIDOCAINE HCL	MPM Medical LLC	c3eec066-38e8-4617-b34d-2f72ffb7a324	2026-03-30	Warnings	Exact identifier ndc (package): 66977-107-03 ndc (package): 66977-107-04 ndc (package): 66977-107-05 ndc (product): 66977-107 ndc11 (package): 66977010704 ndc11 (package): 66977010705 ndc11 (package): 66977010703 spl id: 4e446d3e-615b-5079-e063-6394a90aca13 spl set id: c3eec066-38e8-4617-b34d-2f72ffb7a324

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.